Last updated: 2026-09-16 09:05:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
LivaNova PLC (LIVN) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $79.25, with a market capitalisation of $4.44B and a P/E ratio of 23.22. Over the past 52 weeks, its price has ranged from $48.82 to $85.76. This page covers its latest market performance, valuation, price trends and company information.
$4.44B | |
$79.43 | |
$131.54 | |
$32.48 | |
$79.47 | |
11.00 | |
671.18K | |
23.22 | |
$85.76 | |
$48.82 | |
-- | |
-- |
LivaNova PLC (LIVN) is trading at $79.25 in pre-market trading as of 2026-09-16 08:59:00, down 0.27% ($0.22) from the previous close of $79.47
Pre-market trading shows how investors are pricing LIVN before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, LivaNova PLC (LIVN) moved from $81.92 to $79.25, representing a decline of 3.26% ($2.67).
The stock traded between $77.15 and $82.22 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 514.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 82.4%
LIVN is currently trading at $79.25, placing it 82.4% of the way from its 52-week low of $48.82 to its 52-week high of $85.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 3300 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LivaNova PLC (LIVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.